These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24174884)

  • 21. Development of Hormonal Intravaginal Rings: Technology and Challenges.
    Rafiei F; Tabesh H; Farzad S; Farzaneh F; Rezaei M; Hosseinzade F; Mottaghy K
    Geburtshilfe Frauenheilkd; 2021 Jul; 81(7):789-806. PubMed ID: 34276064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compartmental transport model of microbicide delivery by an intravaginal ring.
    Geonnotti AR; Katz DF
    J Pharm Sci; 2010 Aug; 99(8):3514-21. PubMed ID: 20222027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.
    Rosen RK; van den Berg JJ; Vargas SE; Senocak N; Shaw JG; Buckheit RW; Smith KA; Guthrie KM
    Contraception; 2015 Dec; 92(6):596-601. PubMed ID: 26276246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
    Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.
    Friend DR
    Expert Opin Drug Deliv; 2016; 13(4):533-45. PubMed ID: 26742698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications.
    Palanee-Phillips T; Baum MM; Moss JA; Clark MR; Nuttall J; Romano JW
    Expert Opin Drug Deliv; 2022 Jan; 19(1):47-58. PubMed ID: 34958283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbicide vaginal rings: Technological challenges and clinical development.
    Malcolm RK; Boyd PJ; McCoy CF; Murphy DJ
    Adv Drug Deliv Rev; 2016 Aug; 103():33-56. PubMed ID: 26829289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
    Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
    Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future strategies in microbicide development.
    Rosenberg ZF; Devlin B
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):503-13. PubMed ID: 22406260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond HIV microbicides: multipurpose prevention technology products.
    Malcolm RK; Boyd P; McCoy CF; Murphy DJ
    BJOG; 2014 Oct; 121 Suppl 5():62-9. PubMed ID: 25335842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
    Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF
    PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations-A Critical Review.
    Tietz K; Klein S
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31623277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.
    Smith DJ; Wakasiaka S; Hoang TD; Bwayo JJ; Del Rio C; Priddy FH
    J Womens Health (Larchmt); 2008; 17(6):1025-34. PubMed ID: 18681822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
    Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
    J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Gunawardana M; Dawson LN; Olive TJ; Pyles RB; Baum MM
    PLoS One; 2018; 13(8):e0201952. PubMed ID: 30133534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrospun fibers for vaginal anti-HIV drug delivery.
    Blakney AK; Ball C; Krogstad EA; Woodrow KA
    Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
    Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.
    Moss JA; Srinivasan P; Smith TJ; Butkyavichene I; Lopez G; Brooks AA; Martin A; Dinh CT; Smith JM; Baum MM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5125-35. PubMed ID: 24936594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.